I am a GI medical oncologist with a research interest in gastroesophageal cancers and cancer immunotherapy. I completed my clinical training in adult hematology-oncology at the University of Oklahoma and research training at Oklahoma Medical Research Foundation. Educated at N.R.S.Medical College, India, I came to the US to pursue a career in medicine. I did several clinical rotations as well as laboratory-based cancer research before starting a residency in Internal Medicine at Saint Joseph Hospital, Chicago, in 2012. I am board-certified in Internal Medicine (2015).
I started sub-specialty training in hematology-oncology at the University of Oklahoma in July 2015. I also earned a Masters degree in Clinical and Translational Science at the same institution. I became board certified in both Hematology and Medical Oncology in 2018.
I have had the opportunity to serve the American Society of Clinical Oncology (ASCO) as a volunteer. I have been a member of the Trainee Council Working Group, Clinical Practice Guidelines Committee, and the Professional Development Committee at ASCO. I have also served on many guidelines panel for ASCO.
I am a panel member at the National Comprehensive Cancer Network(NCCN). I also serve as a member of the board of directors at the Esophageal Cancer Action Network.
I have been fortunate to receive many awards, including memberships in Alpha Omega Alpha medical honor society and Gold Humanism Honor Society. I also received a merit award from ASCO for my research on cancer immunotherapy.
My current work focuses on novel clinical trials in GI malignancies using cell-free DNA as a correlative marker. Besides, I am also interested in understanding the impact of obesity on immune dysfunction in cancer. My work has been funded by NCCN and Roswell Park Alliance Foundation.
I would like to see myself as a successful Clinical and Translational researcher as well as a compassionate physician and a thought leader in the field of gastrointestinal cancers.